Year in review: Who were the main DCT players in 2022?
Clinical Trials Arena reviews the companies and countries that mentioned decentralization most often in their clinical trial protocols....
Clinical Trials Arena reviews the companies and countries that mentioned decentralization most often in their clinical trial protocols....
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
The promising performance of an experimental HIV vaccine may lead to an effective vaccine strategy for HIV and AIDS....
Tina Graber discusses her career path and current role as Operations Manager for the regulatory service line within the UW Clinical Research Office (CRO)....
Disease and Bernard Coley are utilizing Denise's Parkinson's disease diagnosis as a platform to inform communities of color about the importance of engaging in clinical trials....
As the tolerance bar for excluding clinical trials participants on the grounds of race and sex lowers significantly, exclusion based on cognitive disability still goes on....
Children who participate in clinical trials can help provide researchers with information adults cannot....
UW–Madison was chosen as a Center of Excellence due to its elite level of comprehensive, multi-disciplinary care and access to leading clinical research and new therapies for patients with polycystic kidney disease (PKD)....